Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

Abstract Background Endocrine therapy (ET)-based regimens are the mainstay of treatment for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer. With the introduction of new treatment classes, it is important to examine patient...

Full description

Bibliographic Details
Main Authors: Alison Davie, Gebra Cuyun Carter, Alex Rider, James Pike, Katie Lewis, Abigail Bailey, Gregory L. Price, Francois Ringeisen, Xavier Pivot
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Advanced breast cancer
Health-related quality of life
Real-world evidence
Patient-reported outcomes
Online Access:http://link.springer.com/article/10.1186/s12885-020-07294-2

Internet

http://link.springer.com/article/10.1186/s12885-020-07294-2

Similar Items